VEDBAEK, Denmark, Nov. 14, 2010 (GLOBE NEWSWIRE) — Exiqon A/S (Copenhagen:EXQ) today published data from a clinical study that stratifies colon cancer patients into groups of high, medium and low chances of survival which may prove useful for optimizing the treatment of each individual cancer patient.
Exiqon has analyzed 130 stage II colon cancer patients for [...] http://bit.ly/c9YbqF
No comments:
Post a Comment